Sumitomo Dainippon Pharma (Japan)
Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sumitomo Dainippon Pharma (Japan), Japan, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
50%
Total
Publications
2.1K
Total Open
Publications
1K
Total
Citations
64K
Open Access
Percentage
50%
Total
Publications
2.1K
Total Open
Publications
1K
Total
Citations
64K
Breakdown
Publisher Open
21%
Both
21%
Other Platform Open
8%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 39%
347
Hybrid 22%
195
No Guarantees 39%
352
Other Platform Open
Domain 67%
411
Institution 40%
246
Other Internet 19%
117
Preprint 6%
34
Public 1%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 419 |
doaj.org OAI-PMH Repository | Institution | 181 |
DOI | Other Internet | 111 |
National Institute of Informatics | Institution | 61 |
Europe PMC | Domain | 21 |
bioRxiv | Preprint | 20 |
Research Square | Preprint | 11 |
Unknown Repository | Other Internet | 9 |
Hokkaido University | Institution | 7 |
Figshare | Public | 7 |